Atlas Trials

SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)

Clinical trial NCT04291079 · COMPLETED

Trial details

NCT number
NCT04291079
Sponsor
Scholar Rock, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2020-04-23
Primary completion
2025-04-14
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.